Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.25.1
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   43,124,496    
Beginning balance at Dec. 31, 2023 $ 95,665 $ 431 $ 376,530 $ (281,296)
Increase (Decrease) in Stockholders' Equity        
Net loss (6,635)     (6,635)
Stock-based compensation 3,919   3,919  
Issuance of restricted and performance stock units (in shares)   539,233    
Issuance of restricted and performance stock units   $ 5 (5)  
Exercise of stock options and employee stock purchases under the ESPP (in shares)   24,000    
Exercise of stock options and employee stock purchases under the ESPP 207 $ 1 206  
Ending balance (in shares) at Mar. 31, 2024   43,687,729    
Ending balance at Mar. 31, 2024 $ 93,156 $ 437 380,650 (287,931)
Beginning balance (in shares) at Dec. 31, 2024 44,148,836 44,148,836    
Beginning balance at Dec. 31, 2024 $ 103,907 $ 441 394,726 (291,260)
Increase (Decrease) in Stockholders' Equity        
Net loss (3,834)     (3,834)
Stock-based compensation 2,909   2,909  
Issuance of restricted and performance stock units (in shares)   1,105,214    
Issuance of restricted and performance stock units   $ 11 (11)  
Exercise of stock options and employee stock purchases under the ESPP (in shares)   258,573    
Exercise of stock options and employee stock purchases under the ESPP $ 2,383 $ 3 2,380  
Ending balance (in shares) at Mar. 31, 2025 45,512,623 45,512,623    
Ending balance at Mar. 31, 2025 $ 105,365 $ 455 $ 400,004 $ (295,094)